← Product Code [GEI](/productcode/GEI) · K972161 # BOVIE MODEL X15 (K972161) _Maxxim Medical · GEI · Jun 18, 1997 · General, Plastic Surgery · SESE_ **Canonical URL:** https://fda-staging.innolitics.com/device/K972161 ## Device Facts - **Applicant:** Maxxim Medical - **Product Code:** [GEI](/productcode/GEI.md) - **Decision Date:** Jun 18, 1997 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 878.4400 - **Device Class:** Class 2 - **Review Panel:** General, Plastic Surgery - **Attributes:** Therapeutic ## Indications for Use The BOVIE Mođel X15 Electrosurgical Generator is Indicated for Use in laparoscopic surgical procedures for the cutting and coagulation of human tissue. The BOVIE Model X15 can be used in conjunction with the appropriate accessories and instruments for applications in General Surgery. ## Device Story BOVIE Model X15 is an electrosurgical generator; provides high-frequency electrical energy for cutting and coagulation of human tissue. Used in laparoscopic and general surgical procedures. Operated by surgeons in clinical/OR settings. Device transforms electrical power into RF output delivered via compatible electrosurgical accessories/instruments. Output allows precise tissue management; aids hemostasis and dissection. Benefits include reduced bleeding and efficient tissue separation during surgery. ## Clinical Evidence No clinical data provided; bench testing only. ## Technological Characteristics Electrosurgical generator; provides RF energy for tissue cutting and coagulation. Designed for use with compatible electrosurgical accessories. Operates via standard electrical power input. ## Regulatory Identification An electrosurgical cutting and coagulation device and accessories is a device intended to remove tissue and control bleeding by use of high-frequency electrical current. ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo is a circular seal with the department's name around the perimeter. Inside the circle is an abstract image of an eagle or bird-like figure. The logo is black and white. Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 JUN 18 1997 Maxxim Medical c/o Mr. Michael A. Clark South East Regulatory Associates, Inc. ---------1070 Thornwood Lane Dacula, Georgia 30211-3007 乐 Re: K972161 Trade Name: BOVIE Model X15 Regulatory Class: II Product Code: GEI Dated: June 2, 1997 Received: June 9, 1997 Dear Mr. Clark: We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Good Manufacturing Practice for Medical Devices: General (GMP) regulation (21 CFR Part 820) and that, through periodic GMP inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations. {1}------------------------------------------------ Page 2 - Mr. Michael A. Clark This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. . . . . . . . . . . . If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4595. Additionally, for questions on the promotion and at vertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html". Sincerely yours, Joelle Celia M. Witten, Ph.D., M.D. Director Division of General and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {2}------------------------------------------------ 510(k) Notification BOVIE Model X15 Electrosurgical Generator June 2, 1997 INDICATIONS FOR USE The BOVIE Mođel X15 Electrosurgical Generator is Indicated for Use ´ ' V in laparoscopic surgical procedures for the cutting and coagulation of human tissue. The BOVIE Model X15 can be used in conjunction with the appropriate accessories and instruments for applications in General Surgery. | | Concurrence of CDRH, Office of Device Evaluation (ODE) | |----------------------|-------------------------------------------------------------------------------| | |
(Fraser Sign Off)
Restorative Devices
| | | K972161 | | Prescription Use | | | (Per 21 CFR 801.109) | X | | | OR | | | Over-The-Counter Use | --- **Source:** [https://fda-staging.innolitics.com/device/K972161](https://fda-staging.innolitics.com/device/K972161) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com